Francesco Tonelli
Overview
Explore the profile of Francesco Tonelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
3332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Falsetti I, Palmini G, Iantomasi T, Brandi M, Tonelli F
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794302
Familial adenomatous polyposis (FAP) is a rare disease characterized by the development of adenomatous polyps in the colon and rectum already in adolescence. If left untreated, patients develop colorectal cancer...
2.
Tonelli F, Marini F, Giusti F, Iantomasi T, Giudici F, Brandi M
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894286
Pancreatic neuroendocrine neoplasms (PNENs) affect over 80% of patients with multiple endocrine neoplasia type 1 (MEN1). Surgery is usually the therapy of choice, but the real immediate and long-term therapeutic...
3.
Guasti L, Cianferotti L, Pampaloni B, Tonelli F, Martelli F, Iantomasi T, et al.
Front Endocrinol (Lausanne)
. 2023 Mar;
14:1098366.
PMID: 36864837
Introduction: Both osteoporosis and periodontitis are pathologies characterized by an imbalance in the bone tissue. Vitamin C is an important factor involved in maintaining the health of the periodontium; its...
4.
Tonelli F, Di Martino C, Amorosi A, Mini E, Nesi G
Updates Surg
. 2022 Feb;
74(2):637-647.
PMID: 35217982
Patients with ulcerative colitis (UC) are at risk of developing a colorectal cancer. The aim of this study was to examine our experience in the treatment of ulcerative Colitis Cancer...
5.
Giusti F, Cioppi F, Fossi C, Marini F, Masi L, Tonelli F, et al.
J Clin Endocrinol Metab
. 2021 Dec;
107(5):e2110-e2123.
PMID: 34922358
Context: Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited endocrine cancer syndrome. Multiple gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) affect 30% to 80% of MEN1 patients, with the most common...
6.
Tonelli F, Rossi M, Matucci Cerinic P
Updates Surg
. 2021 Oct;
74(3):1165-1167.
PMID: 34674137
No abstract available.
7.
Marini F, Giusti F, Cioppi F, Maraghelli D, Cavalli T, Tonelli F, et al.
Cells
. 2021 Aug;
10(8).
PMID: 34440663
Primary hyperparathyroidism (PHPT) is the most common endocrinopathy in multiple endocrine neoplasia type 1 (MEN1). Persistent levels of increased parathyroid hormone (PTH) result in a higher incidence of osteopenia and...
8.
Arpa G, Vanoli A, Grillo F, Fiocca R, Klersy C, Furlan D, et al.
Virchows Arch
. 2021 May;
479(4):667-678.
PMID: 33963925
Most Crohn's disease-associated small bowel carcinomas (CrD-SBCs) are diagnosed in advanced stage and have poor prognosis. To improve diagnosis and therapy, a better knowledge of tumour precancerous lesions, histotypes and...
9.
Marini F, Giusti F, Tonelli F, Brandi M
Int J Mol Sci
. 2021 Apr;
22(8).
PMID: 33919851
Pancreatic neuroendocrine tumors (pNETs) are a rare group of cancers accounting for about 1-2% of all pancreatic neoplasms. About 10% of pNETs arise within endocrine tumor syndromes, such as Multiple...
10.
Giudici F, Cavalli T, Luceri C, Russo E, Zambonin D, Scaringi S, et al.
Mediators Inflamm
. 2021 Mar;
2021:8854916.
PMID: 33708009
Background: CARD15/NOD2 is the most significant genetic susceptibility in Crohn's disease (CD) even though a relationship between the different polymorphisms and clinical phenotype has not been described yet. The study...